Senior Director, Oncology Market Access & GTN Strategy

Sanofi; Morristown (NJ); Hybrid; USD 206,000 - 344,000; Full time

Job summary

Sanofi in the US is seeking a Senior Director, Access Strategy for Oncology to lead strategy and execution across pricing, contracting, GTN, and patient access. The role partners with senior leadership to shape market access for a high-impact oncology portfolio.

The candidate will drive cross-functional collaboration, develop compelling value propositions for payers and providers, and ensure alignment with brand plans. Travel ~30% is anticipated.

Qualifications

• Bachelor’s degree required; MBA, MS, PharmD, PhD preferred.
• 10+ years of experience in account management, payer marketing, contracting, pricing, etc.; 7 years in a leadership role.
• Proven track record of managing teams and leading strategic initiatives across complex therapeutic areas.
• Strong leadership, strategic thinking, and financial acumen for market access and GTN.

Responsibilities

• Lead cross-functional access strategy across Market Access Shared Services, Brand Strategy, Medical Affairs, Regulatory, Patient Support Services, distribution and Finance.
• Develop and communicate robust market access strategies and plans, including the brand’s value story.
• Oversee GTN strategy, pricing, rebates, and discounts to maximize net sales and BOI.
• Collaborate with BIS to monitor payer behavior, market trends, and intelligence.
• Travel approximately 30% to field, HQ, and meetings.

Skills

Leadership

Strategic thinking

Analytical mindset

Communication skills

Education

Bachelor's degree

MBA or advanced degree preferred

Job description

Sanofi in the US is seeking a Senior Director, Access Strategy for Oncology to lead strategy and execution across pricing, contracting, GTN, and patient access. The role partners with senior leadership to shape market access for a high-impact oncology portfolio.

The candidate will drive cross-functional collaboration, develop compelling value propositions for payers and providers, and ensure alignment with brand plans. Travel ~30% is anticipated.